From Strategy to Site Activation — Without Delays
We support sponsors in navigating complex regulatory landscapes and delivering clinical studies efficiently across EMEA.
Clinical development in EMEA is complex and small missteps can lead to costly delays, regulatory setbacks, and operational inefficiencies.
We help you navigate these challenges with clarity, structure, and hands-on execution ensuring your study progresses without unnecessary risk.
EMEA Clinical & Regulatory Strategy. Delivered.
We support international and local companies in navigating the EMEA clinical research landscape, from regulatory strategy to study execution.
Our expertise includes ethics submissions, GDPR compliance, biobank regulations, and site coordination. Ensuring a smooth and compliant study start-up process.
Our Core Services
Clinical Study Setup in EMEA
We support the full process of establishing clinical studies in EMEA. From feasibility and site identification to study start-up and execution.
Regulatory & Compliance
We provide expert guidance on ethics approvals, GDPR, and EMEA regulatory requirements to ensure your study is fully compliant.
Project Management & Study Operations
We deliver structured and proactive project management, ensuring efficient coordination, execution, and high-quality outcomes.
International Study Support
We help global companies run studies in EMEA by bridging local regulatory requirements with international study frameworks.
From Feasibility to First Patient In
Feasibility assessment of study model in EMEA
From strategy to execution
Site and investigator identification
Coordination with Ethics Review Authority
Preparation of ethics submissions
Biobank agreements and sample handling setup
Study start-up and site activation
Patient recruitment and operational support
Levander Life Science Consulting is led by a PhD-trained virologist and immunologist from Karolinska Institutet, with extensive experience across both academia and industry.
With a strong foundation in both science and execution, we bridge the gap between regulatory strategy and operational delivery supporting sponsors in high-pressure, complex clinical environments.
We work with both international and Swedish life science companies.
We typically respond within 24 hours
